Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab
Lawren VandeVrede, Renaud La Joie, Sheena Horiki, Nidhi S. Mundada, Mary Koestler, Jihye Hwang, Peter A. Ljubenkov, Julio C. Rojas, Gil D. Rabinovici, Adam L. Boxer, William W. Seeley
Topics & Concepts
MedicineAmyloid (mycology)PathologyAmyloid βDiseaseAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesAmyloidosis: Diagnosis, Treatment, Outcomes